PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells

European Journal of Cancer

Volumn 47, Issue 11, 2011, Pages 1747-1758

  Sato, Fuyuki ^a   Wu, Yunyan ^a,b   Bhawal, Ujjal Kumar ^c   Liu, Yang ^a,b   Imaizumi, Tadaatsu ^a   Morohashi, Satoko ^a   Kato, Yukio ^d   Kijima, Hiroshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c KANAGAWA DENTAL COLLEGE   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bim; CA9 22; CDDP; PER1; PER3

Indexed keywords

BIM PROTEIN; CISPLATIN; PER1 PROTEIN; PER3 PROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER TISSUE; DOWN REGULATION; FEMALE; FIBROBLAST; GINGIVA CANCER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MALE; MOUTH CANCER; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA INTERFERENCE; UPREGULATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GINGIVAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PERIOD CIRCADIAN PROTEINS;

EID: 79959932560     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.02.025     Document Type: Article

References (34)

1. K. Shiga, T. Ogawa, and S. Sagai Management of the patients with early stage oral tongue cancers Tohoku J Exp Med 212 2007 389 396 (Pubitemid 351565836)
2. T. Shibahara, H. Noma, and T. Kakizawa Oral cancer research with an emphasis on genomic analysis Bull Tokyo Dent Coll 43 2002 209 222 [Review]
3. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
4. K. Kohno, T. Uchiumi, and I. Niina Transcription factors and drug resistance Eur J Cancer 41 2005 2577 2586 [Review] (Pubitemid 41540632)
5. P. Jordan, and M. Carmo-Fonseca Cisplatin inhibits synthesis of ribosomal RNA in vivo Nucleic Acids Res 26 1998 2831 2836 (Pubitemid 28297513)
6. Z.H. Siddik Cisplatin: mode of cytotoxic action and molecular basis of resistance Oncogene 22 2003 7265 7269 [Review]
7. M. Komatsu, T. Sumizawa, and M. Mutoh Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance Cancer Res 60 2000 1312 1316 (Pubitemid 30152000)
8. S. Cory, D.C. Huang, and J.M. Adams The Bcl-2 family: roles in cell survival and oncogenesis Oncogene 22 2003 8590 8607 (Pubitemid 38028528)
9. M. Masuda, M. Suzui, J.T. Lim, and I.B. Weinstein Epigallocatechin-3- gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells Clin Cancer Res 9 2003 3486 3491 (Pubitemid 37082748)
10. R. Kummoona, and S. Mohammad Sámi Study of antiapoptotic gene of oral carcinoma by using Bcl-2 oncogene J Oral Pathol Med 37 2008 345 351 (Pubitemid 351814322)
11. E.G. Konstantakou, G.E. Voutsinas, and P.K. Karkoulis Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses Int J Oncol 35 2009 401 416
12. T.T. Tan, K. Degenhardt, and D.A. Nelson Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy Cancer Cell 7 2005 227 238 (Pubitemid 40568682)
13. D.B. Costa, B. Halmos, and A. Kumar BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations PLoS Med 4 2007 1669 1679
14. X. Jin, L.P. Shearman, and D.R. Weaver A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock Cell 96 1999 57 68 (Pubitemid 29044153)
15. H. Tei, H. Okamura, and Y. Shigeyoshi Circadian oscillation of a mammalian homologue of the Drosophila period gene Nature 389 1997 512 516 (Pubitemid 27435329)
16. K. Miyazaki, T. Nagase, and M. Mesaki Phosphorylation of clock protein PER1 regulates its circadian degradation in normal human fibroblasts Biochem J 380 2004 95 103 (Pubitemid 38725733)
17. F. Sato, C. Nagata, and Y. Liu PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells J Biochem 146 2009 833 838
18. X. Yang, P.A. Wood, and C.M. Ansell The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day Chronobiol Int 26 2009 1323 1339
19. L. Fu, H. Pelicano, and J. Liu The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo Cell 111 2002 41 50
20. S.T. Chen, K.B. Choo, and M.F. Hou Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers Carcinogenesis 26 2005 1241 1246
21. T. Suzuki, F. Sato, and J. Kondo Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-alpha Biomed Res 29 2008 99 103 (Pubitemid 351753469)
22. S. Gery, N. Komatsu, and L. Baldjyan The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells Mol Cell 22 2006 375 382
23. Q. Cao, S. Gery, and A. Dashti A role for the clock gene per1 in prostate cancer Cancer Res 69 2009 7619 7625
24. S. Honma, T. Kawamoto, and Y. Takagi Dec1 and Dec2 are regulators of the mammalian molecular clock Nature 419 2002 841 844 (Pubitemid 35238570)
25. S. Koyanagi, Y. Kuramoto, and H. Nakagawa A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells Cancer Res 63 2003 7277 7283 (Pubitemid 37413468)
26. F. Luciano, A. Jacquel, and P. Colosetti Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function Oncogene 22 2003 6785 6793 (Pubitemid 37372218)
27. A. Egle, A.W. Harris, and P. Bouillet Bim is a suppressor of Myc-induced mouse B cell leukemia Proc Natl Acad Sci USA 101 2004 6164 6169 (Pubitemid 38520545)
28. Y. Zhu, B.J. Swanson, and M. Wang Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells Proc Natl Acad Sci USA 101 2004 7681 7686 (Pubitemid 38658089)
29. C.A. Harris, and E.M. Johnson Jr. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons J Biol Chem 276 2001 37754 37760
30. M.Y. Yang, J.G. Chang, and P.M. Lin Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3 Cancer Sci 97 2006 1298 1307
31. Y.M. Lin, J.H. Chang, and K.T. Yeh Disturbance of circadian gene expression in hepatocellular carcinoma Mol Carcinogen 47 2008 925 933
32. Y. Liu, F. Sato, and T. Kawamoto Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 inhuman breast cancer cells Genes Cells 15 2010 315 325
33. J. Chakrabarti, H. Turley, and L. Campo The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers Br J Cancer 91 2004 954 958 (Pubitemid 39273790)
34. V.Y. Gorbacheva, R.V. Kondratov, and R. Zhang Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex Proc Natl Acad Sci USA 102 2005 3407 3412 (Pubitemid 40328058)